Company
United StatesPublic company, NASDAQ: RNXTRenovoRx, Inc. (NASDAQ: RNXT), Los Altos, CA – FDA Inspections
Inspection records and compliance data for RenovoRx, Inc. in Los Altos, California. 3 FDA inspections on record, last inspected June 16, 2026. Publicly traded as NASDAQ: RNXT.
Company Profile
This profile covers RenovoRx, Inc. based in Los Altos, California, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected May 18, 2016. Last inspected June 16, 2026.
Most cited issue areas
- Report of Death or Serious Injury1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 16, 2026 | Not classified | Medical Devices & Rad Health | 1324452 |
| April 4, 2022 | VAI | Medical Devices & Rad Health · Compliance: Devices | 1166306 |
| May 18, 2016 | NAI | Medical Devices & Rad Health · Compliance: Devices | 978263 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
RenovoRx, Inc.
Stock ticker
RNXT
Exchange
NASDAQ
Share price
$1.20
Market cap
$53.9M
Price as of
November 6, 2026
FEI Number
3011279674
Address
4546 El Camino Real Ste B1, Los Altos, California 94022, United States
Country
United States
ID: 53ed9d73-0643-4791-8e37-cd5a04c834fd